NM_004119.3:c.580G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004119.3(FLT3):​c.580G>A​(p.Val194Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00469 in 1,613,596 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0042 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 26 hom. )

Consequence

FLT3
NM_004119.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: 1.01

Publications

31 publications found
Variant links:
Genes affected
FLT3 (HGNC:3765): (fms related receptor tyrosine kinase 3) This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. This receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia. [provided by RefSeq, Jan 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00608474).
BP6
Variant 13-28052579-C-T is Benign according to our data. Variant chr13-28052579-C-T is described in ClinVar as Benign. ClinVar VariationId is 134446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00424 (646/152300) while in subpopulation NFE AF = 0.00582 (396/68028). AF 95% confidence interval is 0.00535. There are 4 homozygotes in GnomAd4. There are 319 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 646 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004119.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FLT3
NM_004119.3
MANE Select
c.580G>Ap.Val194Met
missense
Exon 5 of 24NP_004110.2
FLT3
NR_130706.2
n.646G>A
non_coding_transcript_exon
Exon 5 of 25

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FLT3
ENST00000241453.12
TSL:1 MANE Select
c.580G>Ap.Val194Met
missense
Exon 5 of 24ENSP00000241453.7
FLT3
ENST00000380987.2
TSL:1
n.580G>A
non_coding_transcript_exon
Exon 5 of 25ENSP00000370374.2

Frequencies

GnomAD3 genomes
AF:
0.00424
AC:
646
AN:
152182
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000628
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00406
Gnomad ASJ
AF:
0.0248
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00480
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00582
Gnomad OTH
AF:
0.00717
GnomAD2 exomes
AF:
0.00501
AC:
1259
AN:
251274
AF XY:
0.00522
show subpopulations
Gnomad AFR exome
AF:
0.000800
Gnomad AMR exome
AF:
0.00290
Gnomad ASJ exome
AF:
0.0261
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00453
Gnomad NFE exome
AF:
0.00609
Gnomad OTH exome
AF:
0.00571
GnomAD4 exome
AF:
0.00474
AC:
6921
AN:
1461296
Hom.:
26
Cov.:
30
AF XY:
0.00482
AC XY:
3507
AN XY:
726964
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33464
American (AMR)
AF:
0.00269
AC:
120
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
0.0237
AC:
618
AN:
26118
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39692
South Asian (SAS)
AF:
0.00190
AC:
164
AN:
86200
European-Finnish (FIN)
AF:
0.00427
AC:
228
AN:
53400
Middle Eastern (MID)
AF:
0.00572
AC:
33
AN:
5768
European-Non Finnish (NFE)
AF:
0.00488
AC:
5421
AN:
1111640
Other (OTH)
AF:
0.00515
AC:
311
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
318
636
955
1273
1591
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00424
AC:
646
AN:
152300
Hom.:
4
Cov.:
32
AF XY:
0.00428
AC XY:
319
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.000626
AC:
26
AN:
41556
American (AMR)
AF:
0.00405
AC:
62
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0248
AC:
86
AN:
3470
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5190
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4824
European-Finnish (FIN)
AF:
0.00480
AC:
51
AN:
10614
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00582
AC:
396
AN:
68028
Other (OTH)
AF:
0.00710
AC:
15
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
32
64
96
128
160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00619
Hom.:
5
Bravo
AF:
0.00400
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00721
AC:
62
ExAC
AF:
0.00516
AC:
626
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00557
EpiControl
AF:
0.00694

ClinVar

Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.33
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.29
T
Eigen
Benign
-0.014
Eigen_PC
Benign
0.026
FATHMM_MKL
Benign
0.45
N
LIST_S2
Benign
0.79
T
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.0061
T
MetaSVM
Benign
-0.47
T
MutationAssessor
Benign
1.7
L
PhyloP100
1.0
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.38
N
REVEL
Benign
0.22
Sift
Benign
0.072
T
Sift4G
Benign
0.11
T
Polyphen
0.95
P
Vest4
0.27
MVP
0.64
MPC
0.17
ClinPred
0.0065
T
GERP RS
3.6
Varity_R
0.087
gMVP
0.58
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146030737; hg19: chr13-28626716; COSMIC: COSV54058930; API